These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19181962)

  • 1. Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
    Kroll J; Epting D; Kern K; Dietz CT; Feng Y; Hammes HP; Wieland T; Augustin HG
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H893-9. PubMed ID: 19181962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
    Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Yin L; Morishige K; Takahashi T; Hashimoto K; Ogata S; Tsutsumi S; Takata K; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2007 May; 6(5):1517-25. PubMed ID: 17513600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.
    Ispanovic E; Serio D; Haas TL
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C600-10. PubMed ID: 18562481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade.
    Sini P; Wyder L; Schnell C; O'Reilly T; Littlewood A; Brandt R; Hynes NE; Wood J
    Clin Cancer Res; 2005 Jun; 11(12):4521-32. PubMed ID: 15958638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-Induced Endothelial Podosomes via ROCK2-Dependent Thrombomodulin Expression Initiate Sprouting Angiogenesis.
    Kuo CH; Huang YH; Chen PK; Lee GH; Tang MJ; Conway EM; Shi GY; Wu HL
    Arterioscler Thromb Vasc Biol; 2021 May; 41(5):1657-1671. PubMed ID: 33730876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.
    Bryan BA; Dennstedt E; Mitchell DC; Walshe TE; Noma K; Loureiro R; Saint-Geniez M; Campaigniac JP; Liao JK; D'Amore PA
    FASEB J; 2010 Sep; 24(9):3186-95. PubMed ID: 20400538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
    Xu H; Czerwinski P; Hortmann M; Sohn HY; Förstermann U; Li H
    Cardiovasc Res; 2008 May; 78(2):349-55. PubMed ID: 18056764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.
    Buharalioglu CK; Song CY; Yaghini FA; Ghafoor HU; Motiwala M; Adris T; Estes AM; Malik KU
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1043-55. PubMed ID: 21642504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afadin Facilitates Vascular Endothelial Growth Factor-Induced Network Formation and Migration of Vascular Endothelial Cells by Inactivating Rho-Associated Kinase Through ArhGAP29.
    Tagashira T; Fukuda T; Miyata M; Nakamura K; Fujita H; Takai Y; Hirata KI; Rikitake Y
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1159-1169. PubMed ID: 29599137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
    Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
    Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
    Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
    Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H; Shimizu K
    Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.